Goldman Sachs takes some of the shine off of Clorox's (CLX) FQ2 earnings beat (I, II) by noting...


Goldman Sachs takes some of the shine off of Clorox's (CLX) FQ2 earnings beat (I, II) by noting transitory factors had a significant role. The firm thinks a lease-back gain and revenue pulled forward from FQ3 made the the company's numbers rosier than they actually were.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs